Sarcoidosis modelling is carried out in vitro using human lung cells and in vivo in mice with the experimentally induced fibrosis and lung granulomas, as well as in animals with impaired expression of the Tcs2 gene—an activator of the mTOR signalling pathway. The gene discussed is POLR1D; the disease is sarcoidosis.